Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,372 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07614776RecruitingPhase 3
New Eye Injection Treatment for Age-Related Macular Degeneration
This study tests whether a new eye injection called ABP 938 works as well as or better than the current standard treatment (Eylea) for wet age-related macular degeneration—a condition that causes vision loss in the center of your sight. You would receive injections into your eye every month for a year.
Fullerton, CaliforniaAges 50 years+ - NCT07221357RecruitingPhase 2/Phase 3
Pumitamig plus chemo vs standard care for new colorectal cancer
This trial tests a new drug called Pumitamig combined with chemotherapy against standard bevacizumab plus chemotherapy for people with advanced colorectal cancer that cannot be surgically removed and hasn't been treated yet. The goal is to see which combination works better and is safer.
Tucson, ArizonaAges 18 years+ - NCT07692789Recruiting
Phone reminders before a bladder test
This study tests if phone calls and MyChart reminders help women prepare for a urodynamics test (a test that checks how your bladder works). You may be able to take part if you are a woman scheduled for this test at certain Ohio State clinics.
Columbus, OhioAges 18 years+ - NCT07426757RecruitingPhase 1
A study of PF-07994525 for advanced multiple myeloma
This trial tests an experimental drug, PF-07994525, for people with advanced multiple myeloma that has not responded to or could not tolerate at least 3 prior treatments. The goal is to see if it can help control the cancer.
Coral Gables, FloridaAges 18 years+ - NCT07282574RecruitingPhase 2
Testing a new study drug for progressive MS
This trial tests a new study drug added to your current MS treatment (ocrelizumab) for people with progressive MS. It aims to see if the combination works better than ocrelizumab alone.
Camperdown, New South WalesAges 18–60 - NCT07587242RecruitingPhase 3
Testing a New Therapy for DMD with Exon 44 Mutations
This study tests whether a new medicine called AOC 1044 (delpacibart zotadirsen) can help boys with Duchenne muscular dystrophy (DMD) who have a specific genetic mutation. The medicine works by helping the body skip a damaged part of the gene to make a functional protein.
LeuvenAges 7–16 - NCT07761728Enrolling by invitation
Comparing two heart PET scan tracers
This study compares two types of radioactive tracers used during heart PET scans to see if one is better at detecting blocked arteries. Participation involves receiving one of the tracers during your routine scan and may help improve heart disease diagnosis.
Los Angeles, CaliforniaAges 18 years+ - NCT06927466RecruitingPhase 1
B019 for relapsed or refractory B-cell acute lymphoblastic leukemia
This trial tests a new treatment called B019 for people whose B-cell acute lymphoblastic leukemia has come back or not responded to standard therapy. The treatment targets specific proteins on the cancer cells to help your immune system fight the leukemia.
BeijingAges 3–25 - NCT06274788Recruiting
Safety study of long-term Omegaven for liver problems from IV nutrition
This study checks if children who need Omegaven for eight weeks or longer develop a lack of essential fats. It is for kids with liver issues caused by IV nutrition who cannot eat or digest food normally.
Fountain Valley, CaliforniaAges 1 day–17 years - NCT06865690Enrolling by invitation
CPR teaching methods for home nurses in Qatar
This study tests two different ways of teaching CPR to private home nurses in Qatar. The goal is to see which method helps you learn and remember CPR skills better, so you can feel more confident in an emergency.
DohaAges Up to 60 years - NCT06657534Recruiting
Push-pull blood draw through central lines in children
This trial tests if using a push-pull method to collect blood from a central line (a special IV) causes less red blood cell damage and blood loss in hospitalized children compared to the standard method.
GhentAges birth–18 years - NCT06365177Recruiting
Comparing sit-to-stand test in person vs. video call
This study compares how well a simple sit-to-stand test works when done in person versus through a video call. It helps doctors understand if a telehealth visit can accurately measure your leg strength and mobility.
BrestAges 65–110 - NCT06295783Recruiting
Study of questionnaires for radiation side effects in head and neck cancer
This study looks at how different questionnaires can better measure the side effects of radiation treatment for head and neck cancer. If you are a current or recent patient, your answers could help improve how doctors monitor and manage these side effects.
Houston, TexasAges 18 years+ - NCT05537116Enrolling by invitation
Mobile texts to help reduce cannabis-impaired driving
This trial tests a brief set of interactive phone messages to help people cut down on driving after using cannabis. You may be a good fit if you’ve driven soon after cannabis use several times recently and can complete the text-and-email steps.
Bowling Green, KentuckyAges 18–29 - NCT07764679RecruitingPhase 3
Brain scan to detect Alzheimer's plaques
This study tests a new PET brain scan that uses a special dye to show amyloid plaques, which are linked to Alzheimer's disease. It may help doctors see if your memory problems are caused by Alzheimer's or something else.
Beijing, Beijing MunicipalityAges 40 years+ - NCT07743463RecruitingPhase 3
Daily pill for weight loss in adults with overweight or obesity
This trial tests an investigational once-daily pill (ASC30) to see if it can help adults with overweight or obesity lose weight. You may be able to join if you have a high body mass index (BMI) and have tried to lose weight before.
Birmingham, AlabamaAges 18 years+ - NCT07743450RecruitingPhase 3
Once-daily pill for weight loss in people with type 2 diabetes
This study tests an oral medication, ASC30, to see if it helps people with type 2 diabetes who are overweight or obese lose weight and improve blood sugar control. It is a once-daily pill that may offer a new treatment option.
Birmingham, AlabamaAges 18 years+ - NCT07766655RecruitingPhase 3
Medication for quitting smoking
This study tests if an investigational medication helps adults stop smoking. Participation takes place of over several weeks, and may increase your chances of quitting successfully.
Little Rock, ArkansasAges 18–65 - NCT07766395Recruiting
Daily powder for women's wellness and fitness
This trial tests a daily powder supplement designed to support lean muscle, hormone balance, digestion, and skin, hair, and nail health. If you're an active woman with some common wellness concerns, this study may help you see if the supplement makes a difference.
Las Vegas, NevadaAges 21–45 - NCT06749457RecruitingPhase 1/Phase 2
Study of a new drug for healthy adults and kidney patients on dialysis
This trial tests a new drug called AZD7760 in two groups: healthy adults (Phase I) and adults with end-stage kidney disease who are on hemodialysis through a central venous catheter (Phase IIa). The goal is to see how safe the drug is and how the body processes it. This could lead to a new treatment option for people on dialysis.
Huntsville, AlabamaAges 18–55 - NCT07765745Recruiting
Thymoquinone gel for preserving jawbone after tooth removal
This study tests a gel made from thymoquinone, a compound found in black seed, to see if it helps preserve the bone where a tooth was removed. It may help keep the jawbone strong for future dental work.
Kafr ash Shaykh, KafrelsheikhAges 18–50 - NCT07351058RecruitingPhase 3
Enicepatide for weight loss in people with type 2 diabetes
This trial tests an investigational medication, Enicepatide, to see if it helps people with obesity or overweight and type 2 diabetes lose weight and improve blood sugar control. You will receive weekly injections and regular check-ups.
Guntersville, AlabamaAges 18 years+ - NCT06824467RecruitingPhase 3
Maintenance Therapy Study for Recurrent Ovarian Cancer
This study tests a new maintenance treatment (sacituzumab tirumotecan) versus standard care for people with ovarian cancer that has come back after responding to platinum-based chemotherapy. The goal is to see if it can keep the cancer from growing longer and improve quality of life.
Birmingham, AlabamaAges 18 years+ - NCT06508892Recruiting
Using a fitness tracker to check fall risk
This study tests whether a fitness tracker or smartwatch can help detect your risk of falling. You will wear a device and do some simple movements, and the researchers will see if the device can warn you or your doctor about a fall risk.
Flint, MichiganAges 65 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,372 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.